Home
BPH Energy Ltd
ASX Code
BPH
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
http://bphenergy.com.au/investor/index.html
Website
http://bphenergy.com.au/
About
BPH is a diversified company holding investments in biotechnology and resources. BPH holds a significant interest (26%) in unlisted oil and gas exploration company Advent Energy Ltd. BPH is commercialising a portfolio of Australian biomedical technologies emerging from collaborative research by leading universities, medical institutes and hospitals across Australia. Biomedical technologies in the commercialisation stage include:
- Cortical Dynamics’ Brain Anaesthesia Response (BAR) Monitor; a device that measures a patient’s brain electrical activity (EEG) to indicate the response to drugs administered during surgery
- HLS5 Tumour Suppress Gene; a genetic marker for early and accurate cancer detection Molecular Discovery Systems (MDSystems), launched in 2006 and spun off from BPH in 2009, is a subsidiary of BPH for drug discovery and validation of biomarkers for disease, therapy and diagnostics.